AI GxP validation for regulated life sciences
Validation

The Validation Master Plan: What It's For and What to Put In It

What a VMP is, what belongs in it and what does not, how it differs from a validation plan for one system, and why the document inspectors ask for first is so often out of date.

Cybroscape Technologies5 min read

Key takeaway

What a VMP is, what belongs in it and what does not, how it differs from a validation plan for one system, and why the document inspectors ask for first is so often out of date.

The Validation Master Plan is usually the first document an inspector asks for, and very often the one least connected to what the company actually does. It gets written once for an audit, approved, filed, and then reality moves on without it.

Which is a shame, because a good VMP is genuinely useful: it's the document that says what you validate, how you decide how much, and who signs. Here's what belongs in one and what doesn't.

What it is, and what it isn't

A VMP is a programme-level document. It describes your validation approach across the site or organisation: scope, governance, methodology, responsibilities, and how you keep validated status alive.

It is not a validation plan for one system. That document — often called a VP or CSVP — covers a single system: its requirements, its risk assessment, its testing, its acceptance criteria. People conflate the two and end up with either a VMP full of system detail that dates instantly, or a system plan pretending to be a programme document.

Useful test: if a sentence would change when you buy a new LIMS, it belongs in the system plan, not the VMP.

What belongs in it

  • Scope. Which sites, systems and processes it covers — and explicitly what it does not.
  • How you decide what is GxP-relevant. The criteria, not the list. See what makes a system GxP-relevant.
  • Your risk methodology. How risk is assessed and how the result changes validation effort. This is the heart of the document under CSA.
  • System categorisation. How GAMP categories are assigned and what each implies for deliverables.
  • The deliverable set. Which documents exist at each category and risk level, and who approves each. See roles and responsibilities.
  • Lifecycle maintenance. Change control, periodic review frequency by risk, revalidation triggers, decommissioning.
  • Supplier management. How supplier evidence is assessed and leveraged.
  • Training and competence for people performing validation.
  • A system inventory — or better, a reference to the inventory, so the VMP doesn't go stale every time a system is added.

What to keep out

  • Detail about specific systems. It ages badly and forces a VMP revision for routine change.
  • The inventory itself, embedded. Reference it; a living list maintained elsewhere stays accurate.
  • Project timelines. They belong to projects.
  • Copied regulation. Reproducing Annex 11 clauses adds pages and no control. Reference and move on.
  • Aspiration. If it says you do quarterly periodic reviews and you do not, you have written your own finding.

That last one is the real risk with this document. An inspector reads the VMP first and then checks whether it is true. A modest plan you follow beats an ambitious one you don't, every time.

Keeping it alive

Give it an owner and a review cycle, like any other controlled document. Review it when your approach genuinely changes — a move to risk-based testing, a new categorisation model, a reorganisation of who approves what — not on a calendar reflex.

A short, current VMP that matches practice is worth more than a comprehensive one that describes a company you used to be. If yours has drifted, the fastest honest fix is to rewrite it to describe what you actually do now, then improve the practice and the document together.

For what sits underneath it, see computer system validation, GxP risk assessment, and the tooling landscape in GxP software.

Where to go next

Explore Cybroscape GxP Copilot for AI-native validation, Cybroscape TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.

Part of our guide to GxP software — categories, evaluation criteria and how the platforms compare.

Validation planReported inValidation summary report
User requirements (URS)verified byPerformance qualification (PQ)
Functional specification (FS)verified byOperational qualification (OQ)
Design specification (DS)verified byInstallation qualification (IQ)
Build and configure the system
Risk assessment at every stageTraceability matrix links each row
The V-model under GAMP 5: each specification on the left is verified by the qualification on the right, and the traceability matrix links every row. Risk assessment runs through all of it.
See it on your own systemBring a URS or a system. We run GxP Copilot against it live on the call.

Sources

Primary documents referred to on this page, from their official publishers.

validation master planvmp pharmawhat is a validation master planvmp template contentsvalidation plan vs master plan
FAQ

Frequently Asked Questions

Prefer to talk first? Chat with us on WhatsApp or book a call with an expert.

What is a Validation Master Plan?

A programme-level document describing your validation approach across a site or organisation: scope, how you decide what is GxP-relevant, your risk methodology, system categorisation, the deliverable set and approvers, lifecycle maintenance, supplier management and training. It is usually the first document an inspector asks for.

What is the difference between a VMP and a validation plan?

A VMP is programme level; a validation plan covers one system — its requirements, risk assessment, testing and acceptance criteria. A useful test: if a sentence would change when you buy a new LIMS, it belongs in the system plan, not the VMP.

What should be left out of a VMP?

Detail about specific systems, the embedded system inventory (reference a living list instead), project timelines, copied regulation text, and anything aspirational. An inspector reads the VMP first and then checks whether it is true, so a modest plan you follow beats an ambitious one you do not.

How often should a VMP be updated?

When your approach genuinely changes — a move to risk-based testing, a new categorisation model, a reorganisation of who approves what — rather than on a calendar reflex. Give it a named owner and a review cycle like any other controlled document.

What if our VMP no longer matches what we do?

Rewrite it to describe current practice, then improve practice and document together. A VMP that describes a company you used to be is worse than a short accurate one, because the gap between the two is exactly what an inspection surfaces.

Keep reading

All articles
ValidationKeeping a SaaS system validated when the vendor releases on its own scheduleSaaS systems stay validated through a release routine: screen release notes, assess risk to GxP functions you use, test what matters in a preview environment, and record the decision. Most releases need only the assessment. · 3 min readValidationSpreadsheet validation in GxP: inventory first, template secondSpreadsheets that support GxP decisions need validation proportionate to what they do: template control for simple forms, verified and locked formulas for calculations, and software-level care, or replacement, for anything with macros. · 3 min readValidationTechnology Transfer in Pharma: The Validation Checklist Nobody Gives YouWhen pharmaceutical manufacturing moves between sites, the validation workload is enormous and poorly documented. Here is the checklist that experienced transfer teams actually use. · 6 min readValidationTypes of Validation in Pharma: IQ, OQ, PQ, Process, Cleaning, and CSV ExplainedA practitioner's walkthrough of every validation type in pharmaceutical manufacturing: what each one covers, when it applies, and how they connect to each other. · 7 min readValidationWriting a user requirements specification that can actually be testedA good URS states business needs in terms two people would judge the same way, keeps needs separate from design choices, flags GxP-relevant requirements, and stays short enough to trace properly. · 3 min readValidationBioequivalence Studies: GxP Validation and Data Integrity Requirements You Cannot MissBioequivalence data is the regulatory foundation for generic drug approvals. Here is what validation and data integrity look like for the systems that generate, process, and store BE study data. · 5 min readValidationChange control for computerised systems: the part that keeps validation trueChange control keeps a system validated after go-live. Its core is a real impact assessment: what the change could affect, how you will show it didn’t, and testing proportionate to that risk. · 3 min readValidationComputer System Validation (CSV): The Complete 2026 GuideCSV validation explained end to end: what computer system validation is, what regulators require, the CSV lifecycle stage by stage, examples by system type, deliverables, common failures and how CSA changes the effort model. · 15 min read

Bring a system. We'll show you the package.

Book a demo, or ask a validation lead a quick question on WhatsApp.

  • We reply within one business day
  • We run your URS live on the call
  • You get a clear plan for your system
Chat on WhatsApp

Book a demo

Four fields. The right specialist replies within one business day.

Your details stay private. We never share them.